CFO Peter Garcia buys 12,000 ALXO shares at $8.53; stock now $7.38, down 58.0% from 52-week high.
Peter S. Garcia, CFO of ALX Oncology, purchased 12,000 shares at $8.53 on 2024-06-13, increasing his holdings from 110,348 to 122,348 shares. The acquisition occurred when the stock was already in substantial decline—down 48.1% over the prior 30 days and 58.0% below its 52-week high of $17.56. The company is unprofitable, with a net loss of $35,581,000 in the latest full fiscal year and only $527,000 in recent quarterly revenue, creating a challenging backdrop. The timing of this purchase—after sharp recent losses and amid fundamental weakness—presents a contrarian signal that warrants attention to management's internal perspective on the company's trajectory.